Further immunohistochemical evidence for impaired NO signaling
in the hypothalamus of depressed patients. Ann. N Y Acad. Sci. 973,
91–93.
Boissel J. P., Schwarz P. M. and Forstermann U. (1998) Neuronal-type
NO synthase: transcript diversity and expressional regulation.
Nitric Oxide 2, 337–349.
Bowley M. P., Drevets W. C., Ongur D. and Price J. L. (2002) Low glial
numbers in the amygdala in major depressive disorder. Biol. Psychiatry 52, 404–412.
Bredt D. S. and Snyder S. H. (1989) Nitric oxide mediates glutamatelinked enhancement of cGMP levels in the cerebellum. Proc. Natl
Acad. Sci. USA 86, 9030–9033.
Bredt D. S., Glatt C. E., Hwang P. M., Fotuhi M., Dawson T. M. and
Snyder S. H. (1991) Nitric oxide synthase protein and mRNA are
discretely localized in neuronal populations of the mammalian
CNS together with NADPH diaphorase. Neuron 7, 615–624.
Choi D. W. and Hartley D. M. (1993) Calcium and glutamate-induced
cortical neuronal death. Res. Pub. Assoc. Res. Nerv Ment Dis. 71,
23–34.
Corder R., Pralong F. P., Muller A. F. and Gaillard R. C. (1990) Regional
distribution of neuropeptide Y-like immunoreactivity in human
hypothalamus measured by immunoradiometric assay: possible
influence of chronic respiratory failure on tissue levels. Neuroendocrinology 51, 23–30.
Cotter D., Mackay D., Landau S., Kerwin R. and Everall I. (2001)
Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry
58, 545–553.
Cotter D., Mackay D., Chana G., Beasley C., Landau S. and Everall I. P.
(2002) Reduced neuronal size and glial cell density in area 9 of the
dorsolateral prefrontal cortex in subjects with major depressive
disorder. Cereb. Cortex 12, 386–394.
Cuellar B., Fernandez A. P., Lizasoain I., Moro M. A., Lorenzo P.,
Bentura M. L., Rodrigo J. and Leza J. C. (2000) Up-regulation of
neuronal NO synthase immunoreactivity in opiate dependence and
withdrawal. Psychopharmacology (Berl.) 148, 66–73.
Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S.
H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary
cortical cultures. Proc. Natl Acad. Sci. USA 88, 6368–6371.
Do K. Q., Grima G., Benz B. and Salt T. E. (2002) Glial-neuronal
transfer of arginine and S-nitrosothiols in nitric oxide transmission.
Ann. N Y Acad. Sci. 962, 81–92.
First M. B., Donovan S. and Frances A. (1996) Nosology of chronic
mood disorders. Psychiatr Clin. N. Am. 19, 29–39.
Garthwaite J., Charles S. L. and Chess-Williams R. (1988) Endotheliumderived relaxing factor release on activation of NMDA receptors
suggests role as intercellular messenger in the brain. Nature 336,
385–388.
Garthwaite J., Garthwaite G., Palmer R. M. and Moncada S. (1989)
NMDA receptor activation induces nitric oxide synthesis from
arginine in rat brain slices. Eur. J. Pharmacol. 172, 413–416.
Gerlach M., Blum-Degen D., Ransmayr G., Leblhuber F., Pedersen V.
and Riederer P. (2001) Expression, but not activity, of neuronal
nitric oxide synthase is regionally increased in the alcoholic brain.
Alcohol Alcohol 36, 65–69.
Grima G., Benz B. and Do K. Q. (1997) Glutamate-induced release of
the nitric oxide precursor, arginine, from glial cells. Eur. J. Neurosci. 9, 2248–2258.
Harkin A. J., Bruce K. H., Craft B. and Paul I. A. (1999) Nitric oxide
synthase inhibitors have antidepressant-like properties in mice. 1.
Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 372, 207–213.
Harrison P. J., Procter A. W., Barton A. J., Lowe S. L., Najlerahim A.,
Bertolucci P. H., Bowen D. M. and Pearson R. C. (1991) Terminal
